1. Home
  2. IDN vs RPTX Comparison

IDN vs RPTX Comparison

Compare IDN & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellicheck Inc.

IDN

Intellicheck Inc.

HOLD

Current Price

$6.88

Market Cap

101.6M

Sector

Technology

ML Signal

HOLD

Logo Repare Therapeutics Inc.

RPTX

Repare Therapeutics Inc.

HOLD

Current Price

$2.16

Market Cap

92.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDN
RPTX
Founded
1994
2016
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.6M
92.4M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
IDN
RPTX
Price
$6.88
$2.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$7.33
$3.00
AVG Volume (30 Days)
194.8K
530.7K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$21,968,000.00
$11,870,000.00
Revenue This Year
$12.25
N/A
Revenue Next Year
$11.20
$9.55
P/E Ratio
$666.09
N/A
Revenue Growth
14.20
N/A
52 Week Low
$2.17
$0.89
52 Week High
$7.48
$2.30

Technical Indicators

Market Signals
Indicator
IDN
RPTX
Relative Strength Index (RSI) 59.62 55.66
Support Level $6.25 $2.11
Resistance Level $7.06 $2.27
Average True Range (ATR) 0.37 0.06
MACD 0.00 -0.01
Stochastic Oscillator 79.18 28.13

Price Performance

Historical Comparison
IDN
RPTX

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Share on Social Networks: